Filing Flows

Filing Flows › Target Group (CBDY) › Recalls, complaints & regulation

Target Group (CBDY): recalls and clinical trials

Target Group (CBDY) beyond its filings: 1 recall in the last 12 months (3 in five years, 1 Class I); 10 active clinical trials.

Latest recalls

Target Group's latest quarter

Target Group, Q2 2026: revenue $1.4M (+11% year over year), operating margin -17.4%, net loss $240K, operating cash flow −$223K. The chart follows the revenue to costs, profit and cash.

Questions

Has Target Group had any recalls?

3 recalls on file over five years from the FDA, CPSC and NHTSA; 1 in the last 12 months.

How many clinical trials does Target Group have?

10 active studies on ClinicalTrials.gov, 0 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.